Peptide receptor-targeted radionuclide therapy alters inflammation in atherosclerotic plaques.
Department of Nuclear Medicine, Hannover Medical School, Hannover, Germany.
Imke
I
Schatka
Department of Nuclear Medicine, Hannover Medical School, Hannover, Germany.
Tim
T
Wollenweber
Department of Nuclear Medicine, Hannover Medical School, Hannover, Germany.
Cathleen
C
Haense
Department of Nuclear Medicine, Hannover Medical School, Hannover, Germany.
Friederike
F
Brunz
Department of Nuclear Medicine, Hannover Medical School, Hannover, Germany.
Klaus F
KF
Gratz
Department of Nuclear Medicine, Hannover Medical School, Hannover, Germany. Electronic address: bengel.frank@mh-hannover.de.
Frank M
FM
Bengel
D005260:Female; D006801:Humans; D006937:Hypercholesterolemia / Q000473:pathology; D007249:Inflammation / Q000473:pathology / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D064847:Multimodal Imaging; D018358:Neuroendocrine Tumors / Q000532:radiotherapy; D009942:Organometallic Compounds / Q000627:therapeutic use; D058226:Plaque, Atherosclerotic / Q000473:pathology*; D049268:Positron-Emission Tomography; D019275:Radiopharmaceuticals / Q000627:therapeutic use; D011878:Radiotherapy / Q000379:methods*; D017481:Receptors, Somatostatin / Q000378:metabolism*; D012189:Retrospective Studies; D014057:Tomography, X-Ray Computed
D009942:Organometallic Compounds; D019275:Radiopharmaceuticals; D017481:Receptors, Somatostatin; C574734:SSTR2 protein, human; C513399:gallium Ga 68 dotatate